Medical Biotechnology


Diabetes: Could targeting this protein prevent hypoglycemia?


Recent research in Diabetes found that neuronostatin could prevent hypoglycemia by getting the pancreas to raise blood sugar in two ways. One way is to make less insulin, which is a hormone that reduces blood sugar, and the other is to produce more glucagon, a hormone that increases blood sugar.In the more recent investigation, the scientists showed that injecting rats with neuronostatin raised the animals’ blood sugar levels.
To know more about the target towards various diseases and solutions for those diseases join us at Biotechnology Conference May 20-21,2019 London, UK
Medical Biotechnology  is the field of science that encompasses over the range of areas that target towards various diseases and solutions to those diseases that increase human morbidity and mortality. Biomedical Engineering is an emerging and exciting field that mainly concerned with the development of manufacturing biomedical equipment’s,biopharmaceutical drugs, clinical Researches on drugs and Tissue Engineering toimprove the quality of human life.
  • Track 1-1 Neurobiology and its disorders
  • Track 2-2 Biotechnology in Diagnosis of Disease and its Treatment
  • Track 3-3 Tissue engineering
  • Track 4-4 Clinical Research/ Clinical Trails
Mail us at biotechnology@pulsusmeetings.net

Comments

Popular posts from this blog

Nanotechnology

Pharmaceutical Technology